Anurag Kumar – Biodeal Pharmaceuticals Limited
View Detailed Executive Profile →Professional Overview
- Anurag Kumar is the Founder and Managing Director of Biodeal Pharmaceuticals Limited, which was established in August 2014.
- Under Anurag Kumar's leadership, Biodeal Pharmaceuticals Limited has focused on the development and distribution of innovative pharmaceutical products.
- The organization has implemented advanced biopharmaceutical technologies, contributing to improved drug formulation and delivery systems.
- Biodeal Pharmaceuticals Limited has successfully navigated challenges in the competitive pharmaceutical market by emphasizing research and development.
- Anurag Kumar also held the position of Chairman at Progress Pharma from March 2004 until June 2024, showcasing a long-term commitment to the pharmaceutical industry.
- Throughout the tenure at Progress Pharma, significant milestones were achieved, including the launch of various successful healthcare products.
- Anurag Kumar has actively participated in strategic planning and operational management, leading teams to drive business growth.
- The contributions made to the industry have not only enhanced product offerings but also focused on patient-centered healthcare solutions.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Progress Pharma | Chairman | Mar 2004 – Jun 2024 |
| Biodeal Pharmaceuticals Limited | Founder & Managing Director | Aug 2014 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Biodeal Pharmaceuticals Limited corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Anurag Kumar's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Biodeal Pharmaceuticals Limited's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)